In pressure overload, left ventricular (LV) dilatation is a key step in transition to heart failure (HF). We recently found that collagen VIII (colVIII), a non-fibrillar collagen and extracellular matrix constituent, was reduced in hearts of mice with HF and correlated to degree of dilatation. A reduction in colVIII might be involved in LV dilatation, and we here examined the role of reduced colVIII in pressure overload-induced remodelling using colVIII knock-out (col8KO) mice.
Introduction
Left ventricular (LV) pressure overload, such as seen in patients with aortic stenosis, leads to concentric hypertrophy and fibrosis. 1 If left untreated, concentric LV remodelling may progress to cardiac dilatation and heart failure (HF). 2 Symptomatic patients with aortic stenosis have a poor prognosis unless treated with aortic valve replacement. 3 The mechanisms involved in decompensated LV dilatation are largely unknown. LV remodelling from pressure overload is characterized by cardiomyocyte hypertrophy and quantitative and qualitative alterations in extracellular matrix (ECM) constituents such as collagens. 4 -6 Several collagens are structural proteins providing tissue strength by constituting a scaffold for cardiomyocytes (CM). Alterations in collagen isoforms during pressure overload are linked to compensated LV hypertrophy, 4 overt HF, 5 and reverse remodelling. 4 We recently reported reduced levels of collagen VIII (colVIII) in mice with dilated HF due to LV pressure overload, whereas we did not find any alteration in colVIII in mice with compensated hypertrophy.
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Interestingly, we identified a negative correlation between LV colVIII levels and dilatation, suggesting that colVIII might play a role in transition from concentric compensatory hypertrophy to LV dilatation. ColVIII is a non-fibrillar, short-chain collagen consisting of colVIIIa1 and colVIIIa2 chains encoded by the COL8A1 and COL8A2 genes, respectively. 7 -10 Mutations in colVIII are associated with corneal dystrophy, 11 but the role of colVIII in the heart remains unknown, although its role in bridging ECM molecules 12 predicts that it could affect tissue integrity during LV remodelling. Interestingly, colVIII increases smooth muscle cell migration and maintains their phenotype in the vasculature. 13 -15 This might suggest that colVIII plays a role in cardiac myofibroblast differentiation, a cell type characterized by excessive production of ECM with smooth muscle cell-like phenotype central to development of fibrosis. 16 A recent study 17 on vascular smooth muscle cells has shown that colVIII suppresses ras homologue gene family member A (RhoA) activation via b1 integrin receptors, thereby increasing MMP expression and cellular migration. The aim of this study was to examine the effects of reduced colVIII on myocardial fibroblast differentiation and development of fibrosis, on survival, and on LV dilatation in the acute and more chronic phase of pressure overload. ColVIII knock-out (col8KO) and wild-type (WT) mice were subjected to banding of the ascending aorta (AB) and examined by echocardiography and molecular analyses, while effects of colVIII on cardiac fibroblast (CFB) differentiation were examined in vitro.
Methods
See Supplementary material online for details.
Animal experiments
Animal experiments were approved by The Norwegian Animal Research Committee and conformed to the Guide for the Care and use of Laboratory Animals (NIH). AB 18 was performed blinded to genotype on 7-week-old male col8KO (colVIIIa1 and colVIIIa2 deficient) and C57BL/6JBomTac WT mice (Taconic, Skensved, Denmark) as previously described.
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Col8KO mice are viable, fertile, and show no major abnormalities, 20 and they were crossed back for at least 20 generations onto C57BL/6J background by Dr Ulrike Hopfer and Dr Bjorn R. Olsen at Harvard Medical School (Boston, MA, USA). They were generously provided by Dr Hopfer (University of Basel, Switzerland) and bred by homozygous intercrosses at our institution. To reduce the possibility that different C57BL/6 substrains could contribute to different responses to pressure overload in col8KO and WT mice, 21 both groups were on C57BL/6J background. Animals were maintained in pathogen-free facilities, with free access to water and fed with standard rodent chow. Echocardiographic examination under light sedation with isoflurane was carried out using the VEVO 2100 (VisualSonics, Toronto, Canada) with VEVO 2100 1.1.0 software at several time points for phenotypic characterization. For histological and molecular analyses, mice were randomized to 48 h or 6 weeks of AB, with echocardiography prior to sacrifice. Surgery, echocardiography, and echocardiography analyses were performed blinded to mouse genotype. After sacrifice under anaesthesia breathing 3% isoflurane and 97% oxygen on a mask, heart and lung tissue were weighed, snap-frozen in liquid nitrogen, and stored at 2808C.
Non-invasive blood pressure measurements
Blood pressure was measured blinded to mouse genotype by CODA standard tail-cuff blood pressure system (Kent Scientific, CT, USA). Mice were Figure 1 Decreased survival and increased LV dilatation after induction of LV pressure overload in collagen VIIIa1-and -a2-deficient mice (col8KO).
(A) Kaplan-Meier survival plot of wild-type (WT) and col8KO mice after aortic banding (AB) (n ¼ 28 -33 per group). (B) Lung weights at autopsy (Days 3 -9 after AB) (n ¼ 24 col8KO, n ¼ 11 WT). (C) LV internal diameter in diastole (LVIDd) in WT and col8KO mice preoperatively (0 days) and 1 -56 days after aortic banding (AB) (n ≥ 8 per group). (D) Preoperative blood pressure measurements in WT and col8KO mice (n ¼ 10 -13); MAP, mean arterial pressure. Data are presented as mean + SEM; § P ≤ 0.05 col8KO AB vs. WT AB.
Lack of collagen VIII in pressure overload placed on the heated examination table under light sedation, spontaneously breathing a mixture of 1.5% isoflurane and 98.5% oxygen on a mask. The blood pressure cuff was placed around the root of the tail. Each animal (n ¼ 10 -13) was subjected to seven measurements, and systolic and diastolic blood pressures were calculated as the mean of the recordings accepted by the CODA software.
Histology
Left ventricles were fixed in 4% formaldehyde and embedded in paraffin. Representative 4 mm mid-ventricular sections were stained with Picrosirius Red stain kit (no. 24901 PolyScience, Warrington, PA, USA) and photographed using ×20 objectives (Axiovision Rel 4.6, Carl Zeiss microscope, GMbH, Jena, Germany). For immunohistochemistry, the sections were incubated with colVIIIa1 antibody (Bioss antibodies; no. 7529R, Bioss Inc., Woburn, MA, USA) followed by incubation with biotinylated antirabbit secondary antibody (VectaStain Elite Kit, Burlingame, CA, USA), stained with DAB substrate, and counterstained with Sirius Red/Fast Green solution.
Total LV collagen content
Quantification of hydroxyproline by HPLC-chromatography was used to evaluate total LV collagen content as previously described. 4 
CFB culture
CFBs were isolated from 1-to 3-day-old col8KO and WT mice. 22 Neonatal pups (25 -110 per isolation) were quickly decapitated and hearts immediately removed by a controlled sternotomy. Hearts were placed in cold Hanks Balanced Salt Solution (HBSS) and the LV excised and cut into pieces. CFBs were isolated from LV and maintained in culture essentially as previously described. 23 After serum starvation for 24 h, cells were stimulated with recombinant colVIIIa1 (5-10 mg/mL) or vehicle and subjected to a migration (scratch) assay for 24 h. 22 Briefly, the migration assay consisted of scratching a 90% confluent cell layer using a 10 mL pipette on top of three lines marked under the culture dish. The scratched areas were photographed immediately after the scratching and 24 h later. Additionally, WT CFB stimulated with recombinant colVIIIa1 were photographed at 6, 12, 16, and 20 h. Using Adobe Photoshop, the area of 'wound healing' was calculated. CFB migration was expressed in %. CFB cultures were also prepared from adult mice. Fibroblasts were isolated by cardiac perfusion with collagenase (480 U/mL; Worthington, Lakewood, NJ, USA). After 5 days in culture, cells were starved for 24 h and stimulated with colVIIIa1 (10 mg/mL) or vehicle. RhoA activity was measured in cell lysates using G-LISA RhoA Activation Assay Biochem Kit (BK124Cytoskeleton, Denver, CO, USA), and total RhoA was quantified by RhoA ELISA Assay (BK150, Cytoskeleton). Both assays were used according to manufacturer's guidelines. Adult CFB were also incubated with integrin b1 blocking antibody (ab24693, 10 mg/mL, Clone: P5D2; Abcam, Cambridge, MA, USA).
Immunohistochemistry of neonatal CFBs
Neonatal CFBs grown on Chambered Coverglass (Lab-Tek, Thermo Fischer Scientific Inc., Rochester, NY, USA) were fixed in 4% paraformaldehyde (no. 158127, Sigma Aldrich) and incubated with anti a-SMA (no. A5228, Sigma Aldrich) followed by incubation with Alexa Fluor 488 secondary antibody (Invitrogen, Carlsbad, CA, USA) and Alexa Fluor 546-phallodin (Invitrogen). Cells were imaged using a LSM 710 confocal microscope (Carl Zeiss, GmbH).
In vitro collagen fibre formation assay
Recombinant colVIIIa1 (0.01 mg) was mixed with 10 mg colI (BD Biosciences, Bedford, MA, USA) in 25 mL TES buffer, 2 mL 10 mM ZnSO4, and dH 2 O to a total volume of 50 mL. The mixture was incubated at 378C for 24 h and content examined using an electron microscope by performing negative staining with 2% aqueous uranyl acetate directly on the grids.
Protein extraction and immunoblotting
Protein was extracted and immunoblotted using Criterion Tris-HCl Gel (Bio-Rad, Hercules, CA, USA), run on SDS -PAGE, blotted onto PVDF membranes (GE Healthcare Life sciences, Uppsala, Sweden), and quantitated using chemiluminescence, as previously described. 23 GAPDH was used for loading control.
RNA extraction and real-time PCR
RNA was extracted, quantified, and quality-controlled as previously described. 24 Reverse transcription was performed using iScript cDNA Synthesis Kit (Bio-Rad) prior to quantitative PCR analysis (qPCR).
Statistical analyses
Statistical analyses were performed using Sigma Plot 11 (Systat Software Inc., San Jose, CA, USA). Results are presented as mean + SEM, and a two-tailed significance level of P ≤ 0.05 was used. Survival rates were calculated using Log-rank (Mantel -Cox) test ( Figure 1A ). Two-way ANOVA was used to study the effects of AB and lack of colVIII ( Figures 2A and B, 4A , B, and D, 5A, D, and F, 7A and B). When comparing two groups ( Figures 1B  and D , 5B, E, and G, 6C, 7C -F ), two-sided Student's t-test or MannWhitney Rank Sum Test was used. One-way ANOVA was used in Figure 6B . Correction for multiple comparisons was done using the Holm -Sidak or Dunn's method.
Results

Increased early mortality after induction of LV pressure overload in col8KO mice
As depicted in Kaplan -Meier survival curves ( Figure 1A ), col8KO exhibited increased mortality following AB compared with WT. The increased mortality was obvious within 3 days where 30% of col8KO Lack of collagen VIII in pressure overload mice were dead, compared with 15% of controls, and continued until 9 days after AB where 39 and 23% in col8KO and WT were dead, respectively. After the first 9 days of AB, mortality was stabilized in col8KO and WT. All mice that died within the first 9 days of AB (n ¼ 24 col8KO, n ¼ 11 WT) underwent autopsy. None of the deceased mice showed signs of cardiac or aortic rupture; however, autopsy revealed 1.22-fold higher lung weight in col8KO mice compared with that in WT ( Figure 1B) . We did not observe mortality in sham-operated animals.
LV dilatation after induction of LV pressure overload in col8KO mice
Preoperative echocardiography revealed no differences in diastolic LV internal diameter (LVIDd) between col8KO and WT mice ( Figure 1C) , and preoperative measurements of blood pressure showed no difference in systolic, diastolic, or mean arterial pressure (MAP) between genotypes ( Figure 1D ). Interestingly, echocardiographic assessment at 1, 2, 7, 14, 21, 28, 42, and 56 days after AB revealed LV dilatation at all time points investigated in col8KO mice compared with WT ( Figure 1C) . Consistent with a similar increase in wall thickness in both groups and increased dilatation following AB in col8KO, the increased LV weight seen 6 weeks after AB compared with respective sham was more pronounced in col8KO mice compared with WT ( Table 1) . Despite increased LV dilatation in col8KO cardiac biomarkers of HF, atrial and brain natriuretic peptides (ANP and BNP, respectively) were unaltered after 48 h of AB and similarly increased in both groups following 6 weeks AB ( Table 2 ).
3.3 Attenuated synthesis of fibrillar collagens accompanied by LV dilatation in col8KO mice in response to pressure overload
Interestingly, 48 h after AB, a time point where col8KO mice showed LV dilatation and 1 day before they exhibited increased mortality, the AB-induced approximately three-fold increased mRNA expression of fibrillar collagens I and III (col1/3) seen in WT mice was absent in col8KO mice (Figure 2A) . At the same time point, total collagen content was not yet altered and was not different between groups (Figure 2A) . One week post AB, total collagen was increased in WT mice while the increase in col8KO did not reach statistical significance (see Supplementary material online, Figure SIV) . Following 6 weeks of AB, LV mRNA expression of col1 and 3 was significantly less increased in col8KO compared with WT ( Figure 2B ). In line with this, total LV collagen was increased to a lesser extent in col8KO mice compared with WT at 6 weeks after AB ( Figure 2B ). LV histology confirmed this finding, showing a lower degree of increased collagen accumulation after 6 weeks of AB in col8KO mice compared with WT ( Figure 2C) . Expression of the collagen cross-linking enzyme, lysyl oxydase (LOX), 25 was increased 48 h and 6 weeks after AB; there was, however, no significant difference in LV mRNA expression in col8KO compared with WT mice (Table 2) . Furthermore, there was no difference in the ratio of LOX to total collagen in the two groups. This might suggest that colVIII does not affect LOX-induced collagen cross-linking.
Localization of collagen VIII in the myocardium
ColVIII has been suggested to function as a bridging molecule in the ECM. 12 CFBs are responsible for the production of ECM. Hence, we sought to examine whether colVIII was present in CFB and localized to the ECM. Interestingly, immunoblotting of cell lysate from neonatal CFB and CM demonstrated higher colVIIIa1 protein levels in CFB ( Figure 3A) . In line with this, immunohistochemical detection of colVIIIa1 in the LV tissue sections suggested that colVIIIa1 was localized to CFB and their extracellular surrounding space ( Figure 3B ). Similar to the corneal endothelium, 26 colVIIIa1 was also present in the cardiac endothelium ( Figure 3C ).
To get an indication of whether colVIII affected the structure of other ECM molecules in vitro, we used EM to investigate the role of colVIII in promoting colI fibre formation. Soluble colI will spontaneously form fibres when incubated at 378C for 24 h. Recombinant colVIIIa1 (0.01 mg) was mixed with soluble colI (10 mg) in a test tube. Compared with colI alone (see Supplementary material online, Figure S5A ), this increased the amount of colI fibre formation (see Supplementary material online, Figure S5B ) supporting a role for colVIII in facilitating ECM interactions. No difference in colI fibre diameter was observed.
3.5 Decreased pro-fibrotic TGF-b signalling and differentiation of neonatal CFBs into myofibroblasts in col8KO mice in response to pressure overload
The altered early fibrotic response, i.e. attenuated mRNA expression of col1 and 3 in col8KO mice, suggested that colVIII affects major profibrotic signalling and differentiation of neonatal CFB to myofibroblasts. Interestingly, 48 h after AB expression of the pro-fibrotic cytokine TGF-b was significantly lower in col8KO mice compared with an approximately three-fold increase in WT mice ( Figure 4A) . Accordingly, in isolated neonatal CFB in culture, TGF-b expression was lower in col8KO cells than that in WT ( Figure 4B) . Interestingly, recombinant colVIIIa1 increased TGF-b expression in WT CFB 1.8-fold and rescued the reduced expression of TGF-b in CFB lacking colVIII ( Figure 4B ). There was no significant difference in the relative expression of TGF-b between WT and KO cells, meaning that they have equal response to exogenous colVIII. Reduced TGF-b signalling in col8KO mice was supported by reduced p-SMAD2 protein levels following AB in col8KO mice compared with WT ( Figure 4C and D) . 
Lack of collagen VIII in pressure overload
Importantly, expression of the myofibroblast marker gene a-SMA was increased approximately three-fold in WT and only approximately two-fold in col8KO mice 48 h after AB ( Figure 5A ). Accordingly, a-SMA mRNA expression was reduced in isolated neonatal CFB from col8KO mice compared with WT ( Figure 5B ). Immunohistochemistry also illustrated reduced staining and organization of a-SMA fibres in isolated CFB from col8KO compared with WT ( Figure 5C ). These findings were supported by reduced expression of the myofibroblast marker genes SM22 and Pxn, which were increased in WT mice 48 h after AB, but attenuated in col8KO mice ( Figure 5D and F), and were expressed at a lower level in isolated col8KO CFB compared with WT ( Figure 5E and G).
Finally, we investigated whether colVIII affected the migratory ability of neonatal CFB, another important aspect of their function. Results showed that in contrast to WT CFB (n ¼ 9), which migrated into the scratched zone within 24 h ( Figure 6A and B), col8KO CFB (n ¼ 9) had a slower migration. Interestingly, stimulating col8KO CFB with recombinant colVIIIa1 increased their migratory ability in a dose-dependent manner, resembling the WT response ( Figure 6A and B) . Furthermore, we examined whether recombinant colVIIIa1 affected the migration of WT CFB. Interestingly, recombinant colVIIIa1 also increased the migration of WT CFB (n ¼ 11) in a dose-dependent manner ( Figure 6D ).
In addition to our observation that col8KO CFB proliferate more than WT CFB in cell culture, we measured the level of proliferating cell nuclear antigen (PCNA) expression, a marker of cellular proliferation, which confirmed our observation that col8KO CFB proliferate more rapidly compared with WT CFB (Figure 6C ).
Collagen VIII inhibits RhoA signalling in adult CFBs
RhoA regulates cell dynamics and, especially, aspects of cellular migration. 27 RhoA activity was increased in adult CFB from col8KO mice (Figure7A). Although stimulation with colVIIIa1 did not affect RhoA activity in either genotype significantly, RhoA protein levels were increased in col8KO CFB following stimulation with colVIIIa1, meaning that RhoA activity per RhoA molecule was reduced (Figure7B). We also measured RhoA mRNA in adult CFB from col8KO mice, showing reduced expression ( Figure 7C ). This was confirmed also at the protein level in a total RhoA ELISA ( Figure 7B) . ColVIII has been shown to suppress RhoA activity through integrin b1 in vascular smooth muscle cells. 17 Interestingly, integrin b1 mRNA was significantly reduced in CFB from col8KO mice ( Figure 7D) , and incubation of CFB from WT mice with an integrin b1 blocking antibody increased RhoA activity ( Figure 7E ). RhoA has been reported to suppress migration by inhibiting MMP2 expression and activity, and consistent with this hypothesis, MMP2 mRNA was markedly reduced in CFB lacking colVIII ( Figure 7F ).
Discussion
This study demonstrates the novel findings that lack of colVIII disrupts the acute adaptation of the heart to increased load and is involved in survival and development of LV dilatation during cardiac remodelling in pressure overload. Key findings were increased early mortality and increased LV dilatation in col8KO mice in response to AB in vivo, accompanied by reduced expression of structural col1 and 3, TGF-b signalling, and myofibroblast differentiation. In vitro, neonatal CFB lacking colVIII showed reduced expression of TGF-b and myofibroblast markers a-SMA, Pxn, and SM22. Migratory ability was reduced in CFB from col8KO mice possibly due to increased RhoA activity and reduced MMP2 expression. Stimulation of fibroblasts with recombinant colVIIIa1 increased TGF-b expression and migration, suggesting that colVIII might act as a signalling molecule in the heart directly affecting CFB function. We used an experimental mouse model of AB to induce pressure overload and simulate clinical aortic stenosis. In this model, banding induces an acute LV pressure overload, which stabilizes over time and does not have the same potential for development of collateral circulation compared with transverse aortic constriction. 19 Pressure overload leads to compensated concentric remodelling that may progress to LV dilatation and HF. 2 In the present study, we demonstrate that lack of colVIII in LV pressure overload leads to increased early mortality 3-9 days after AB which may suggest that lack of colVIII disrupted the acute adaption of the heart to increased load. Autopsy findings excluded cardiac or aortic rupture as a cause of death, suggesting that increased early mortality of col8KO mice may be due to a reduced ability of the heart to withstand the acute increased myocardial wall stress. Acute HF as supported by the increased lung weight in the deceased col8KO animals as well as lethal arrhythmias might be considered as possible explanations. We have previously shown that colVIII protein levels in mice subjected to LV pressure overload correlates negatively with LV dilatation. 5 In the present study, we demonstrate that col8KO mice exhibited LV dilatation during remodelling in response to AB. Our data therefore suggested that colVIII is important for the initial survival and LV dilatation in pressure overload of the heart, although the mechanisms behind these findings are not clear. ColVIII is a non-fibrillar collagen suggested to serve as a molecular bridge between different types of ECM molecules. 12 Moreover, colVIII has previously been described as an important factor in tissue repair where it directs adhesion of ECM components, especially the major structural colI. 14 Thus, these effects might be reduced in col8KO mice affecting tissue integrity directly by its absence. This hypothesis is supported by our in vitro findings that colVIII modifies the structural organization of colI. Accumulation of collagens in the ECM, i.e. fibrosis, is thought to contribute to impaired cardiac function and HF, 28 but at the same time, it increases ECM stiffness in the myocardium. In WT mice with initial concentric remodelling in response to AB, the increased collagen amounts, thus increased cardiac stiffness, reduces diastolic function, but also counteracts LV dilatation. Interestingly, in col8KO mice developing LV dilatation, the increased mRNA expression of fibrillar col1 and 3 and total collagen protein were attenuated within the first week of AB. Hence, reduced pressure overload-induced synthesis of the fibrillar collagens might potentially contribute to the LV dilatation and early mortality in col8KO mice. Effects linked to CFB function might also contribute. In the heart, CFBs are responsible for synthesis, deposition, and degradation of collagens and other ECM molecules. 2 In the present study, we have demonstrated that colVIII is synthesized by CFB in vitro and is localized to the ECM in fibroblasts and their surrounding tissue of mouse hearts in vivo. As previously shown, 26 colVIII was also localized to the inner vessel wall/endothelium/endothelial cells. Interestingly, recombinant colVIIIa1 seemed to increase colI fibre formation when mixed in vitro. Although this finding remains to be confirmed in vivo, it might support a role for colVIII in facilitating ECM interactions and that loss of this colVIII isoform may impair the structural integrity of the myocardium leading to LV dilatation. During pressure overload, CFBs differentiate into myofibroblasts, characterized by their increased collagen production and smooth muscle cell-like phenotype, 29 leading to increased fibrosis and stiffness of the heart, counteracting cardiac dilatation. Differentiation of CFB into myofibroblasts is mainly promoted by TGF-b 30, 31 and experimentally defined by increased expression of marker genes a-SMA, Pxn, and SM22. 22 Interestingly, we found that in col8KO mice with LV dilatation, cardiac expression of TGF-b and myofibroblast markers were reduced compared with WT. This suggests that lack of colVIII reduces TGF-b signalling and thereby reduces CFB differentiation into myofibroblasts, suggesting a mechanism for attenuated collagen synthesis and increased LV dilatation. This finding was supported by in vitro studies, demonstrating reduced expression of TGF-b and myofibroblast marker genes in neonatal CFB from mice lacking colVIII. Importantly, attenuated expression of TGF-b in col8KO CFB could be rescued by stimulation with recombinant colVIIIa1, suggesting a direct effect of colVIII on CFB function. The concept of colVIII acting as a signalling molecule within the heart has not been reported previously. Finally, consistent with findings in smooth muscle cells, 14, 15 lack of colVIII led to markedly reduced migration of CFB, another important aspect of CFB function in development of fibrosis. The reduced migratory response in col8KO CFB could be rescued by adding recombinant colVIIIa1, again suggesting that colVIII might affect the fibrotic response of the heart through activation of pro-fibrotic TGF-b signalling, myofibroblast differentiation, and migration. One might speculate that lack of migration of col8KO CFB could be influenced by reduced proliferation compared with WT CFB. However, on the contrary, we have shown that col8KO CFB actually proliferate more than WT CFB, indicating that the reduced migration of CFB in col8KO mice is most likely not a result of reduced proliferation.
To identify a molecular mechanism for the effect of colVIII on CFB migration, we measured levels of MMP2, an ECM enzyme known to promote migration. 32, 33 MMP2 levels were markedly reduced in CFB from adult col8KO mice, possibly accounting for the reduced migration of these cells. MMP2 expression and activation can be suppressed by active RhoA in endothelial cells 34 and vascular smooth muscle cells. 17 We found increased RhoA activity in CFB from col8KO mice. Hence, it is possible that the increased RhoA activity observed in cells lacking colVIII inhibits MMP2 expression and activity also in CFB as shown for vascular smooth muscle cells 17 and that this in turn affects migratory properties. Interestingly, integrin b1 mRNA was significantly reduced in CFB from col8KO mice, and incubation of CFB from WT mice with an integrin b1 blocking antibody increased RhoA activity, suggesting that colVIII signals through integrin b1 to suppress RhoA signalling. Thus, the increased RhoA activity of CFB from col8KO mice could be a result of reduced colVIII-integrin b signalling, as is the case in smooth muscle cells. 17 In the present study, we have measured comparable preoperative blood pressures in col8KO and WT mice, making preoperative hypertension in col8KO mice and its potential effects on early dilatation of the LV after AB less likely. We cannot completely rule out the possibility that different degrees of aortic constriction may contribute to different degree of LV dilatation and increased mortality in col8KO compared with WT mice. However, the banding procedure was carefully standardized and echocardiography showed comparable V max , whereas cardiac output and heart rate were not significantly different. Importantly, all surgery, blood pressure measurements, echocardiography, and data analyses were performed blinded to genotype. Furthermore, animals were randomized to be sacrificed 48 h or 6 weeks after AB.
In conclusion, the present study demonstrates the novel finding that the non-fibrillar colVIII is important for the early adaptation of the heart to pressure overload affecting survival, and development of LV dilatation. Moreover, mice lacking colVIII exhibit attenuated TGF-b signalling which may disrupt the normal myofibroblast differentiation and fibrosis formation in response to pressure overload. We suggest a role for colVIII in regulation of ECM structure and fibrosis in the hearts of patients with aortic stenosis, counteracting LV dilatation.
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